Condition
Joint
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed1
Enrolling By Invitation1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07349264Not ApplicableCompletedPrimary
Flexy3 Supplementation and Joint Health
NCT06811012Phase 1Enrolling By Invitation
Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis
NCT01567696UnknownPrimary
Clinical, Radiographic and Laboratory Analysis of Failures of Joint Replacements
Showing all 3 trials